Healthcare provider profile · identity verified

Chris Casso, M.D.

Family Practice · EDINBURG, TX · NPI 1568543866

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	346	86
Atorvastatin Calcium	Atorvastatin Calcium	337	99
Losartan Potassium	Losartan Potassium	289	83
Rosuvastatin Calcium	Rosuvastatin Calcium	246	71
Montelukast Sodium	Montelukast Sodium	231	64
Amlodipine Besylate	Amlodipine Besylate	229	56
Metformin Hcl	Metformin Hcl	198	65
Lisinopril	Lisinopril	167	41
Fluticasone Propionate	Fluticasone Propionate	145	63
Metoprolol Succinate	Metoprolol Succinate	137	36
Jardiance	Empagliflozin	126	30
Omeprazole	Omeprazole	126	43
Ozempic	Semaglutide	117	26
Pantoprazole Sodium	Pantoprazole Sodium	116	31
Simvastatin	Simvastatin	113	28
Escitalopram Oxalate	Escitalopram Oxalate	104	30
Alendronate Sodium	Alendronate Sodium	102	29
Enalapril Maleate	Enalapril Maleate	100	25
Hydrochlorothiazide	Hydrochlorothiazide	98	30
Sertraline Hcl	Sertraline Hcl	81	20
Tamsulosin Hcl	Tamsulosin Hcl	80	26
Albuterol Sulfate Hfa	Albuterol Sulfate	76	25
Trazodone Hcl	Trazodone Hcl	76	15
Gabapentin	Gabapentin	67	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	66	15
Famotidine	Famotidine	63	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	11
Trulicity	Dulaglutide	62	12
Allopurinol	Allopurinol	60	16
Fluoxetine Hcl	Fluoxetine Hcl	56	13
Clopidogrel	Clopidogrel Bisulfate	53	16
Rybelsus	Semaglutide	51	11
Tradjenta	Linagliptin	47	suppressed
Valsartan	Valsartan	45	11
Prednisone	Prednisone	43	33
Ezetimibe	Ezetimibe	41	13
Kerendia	Finerenone	41	suppressed
Myrbetriq	Mirabegron	41	suppressed
Azithromycin	Azithromycin	40	31
Irbesartan	Irbesartan	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	14
Topiramate	Topiramate	39	suppressed
Fluconazole	Fluconazole	36	14
Baclofen	Baclofen	35	22
Memantine Hcl	Memantine Hcl	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	27
Buspirone Hcl	Buspirone Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	11
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Mometasone Furoate	Mometasone Furoate	33	25
Farxiga	Dapagliflozin Propanediol	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Linzess	Linaclotide	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Eliquis	Apixaban	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Ibuprofen	Ibuprofen	25	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Meloxicam	Meloxicam	25	11
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	23	suppressed
Nystatin	Nystatin	23	suppressed
Rivastigmine	Rivastigmine	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Furosemide	Furosemide	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	15
Bumetanide	Bumetanide	21	suppressed
Clotrimazole	Clotrimazole	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	16
Dutasteride	Dutasteride	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Finasteride	Finasteride	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Januvia	Sitagliptin Phosphate	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Glipizide	Glipizide	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Pen Needles	Pen Needle, Diabetic	17	suppressed
Probenecid	Probenecid	17	suppressed
Naproxen	Naproxen	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ranolazine Er	Ranolazine	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Estradiol	Estradiol	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Metolazone	Metolazone	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Colchicine	Colchicine	12	suppressed
Gemtesa	Vibegron	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Singulair	Montelukast Sodium	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error